Bifidobacterium infantis 35624 is a strain of bacteria isolated from the human intestine, belonging to the group of bifidobacteria. It is a probiotic strain, i.e., live organisms which, according to research, may have a beneficial effect on the digestive system and overall gut health.
It is one of the best-studied probiotics in the context of irritable bowel syndrome (IBS). Clinical studies have focused on assessing the impact of this strain on IBS symptoms such as abdominal pain, bloating and irregular bowel movements. Data suggest that a dose of around 1 x 10^9 CFU/day may bring relief in some patients, but effects vary across populations and study settings. This strain is generally well tolerated by adults.
Relief of IBS symptoms (abdominal pain, bloating, variability of bowel movements)
Clinical studies suggest that B. infantis 35624 may reduce the severity of abdominal pain and bloating in certain IBS patients at doses close to 1 x 10^9 CFU/day.
Potential impact on intestinal comfort and quality of life
Some people show improvements in overall intestinal comfort and quality of life related to IBS symptoms. The results are consistent with the assumption that the probiotic may modulate peristalsis and gut hypersensitivity.
Strengthening of the intestinal barrier
It affects the integrity of the intestinal epithelium and may support protective mechanisms of the mucosa and cell junctions.
Potential regulation of intestinal metabolites
Which affects the functioning of the enteric nervous system.
Production of organic acids
It produces short-chain fatty acids (e.g., acetate), which lower intestinal pH and promote a healthy microbiota.
Modification of the gut microbiota and modulation of the immune system
It may influence the immune response in the intestines, promoting a balance between pro-inflammatory and anti-inflammatory mechanisms.
Competition for niches in the intestine
It supports the growth of beneficial microorganisms and limits the colonisation of potentially harmful species.
Prebiotic action in the context of a diet rich in fibre/oligosaccharides
In combination with prebiotics it may multiply and act more effectively.
The probiotic has undergone careful testing confirming its top quality.
This probiotic is intended primarily for people seeking to improve overall intestinal function and comfort. We particularly recommend it to those experiencing ailments related to IBS, since some studies have observed reductions in bloating, abdominal pain and overall discomfort, which translated into a better quality of life. It is also ideal support for anyone who wants to improve food tolerance and consciously use the latest probiotic mechanisms to strengthen the health of the digestive system.
A dose of about 1 x 10^9 CFU/day is usually used, administered in capsules. The B. infantis 35624 strain has been assessed as safe and well tolerated in adults in clinical studies. As with any probiotic supplementation, if disturbing symptoms occur (e.g., severe abdominal pain, fever, diarrhoea lasting more than a few days), consult a doctor. The probiotic does not replace medical treatment of IBS or other intestinal conditions. Before adding a new probiotic to your treatment plan, consult a doctor, especially if you have chronic illnesses, immunosuppression or take other medications.
Przechowuj w chłodnym, suchym miejscu, z dala od bezpośredniego światła słonecznego. Unikaj przekraczania zalecanej dawki. W przypadku ciąży, karmienia piersią lub schorzeń, przed zastosowaniem skonsultuj się z lekarzem. Suplement diety nie może być stosowany jako zamiennik zróżnicowanej diety.
